Commissioner Califf: Cardiologist, Clinical Trials Expert Ascends At FDA

The Senate confirmed Robert Califf as the new FDA commissioner after months of delay, giving the cardiologist, clinical trial expert and established agency official a better platform to push his priorities, which include combination product and clinical data-collection reforms, while implementing projects already under way.

Robert Califf became the first cardiologist to serve as commissioner of FDA with an 89-4 vote of support in the Senate on Feb. 24.

He will replace acting commissioner Stephen Ostroff, who is expected to remain in the Office of the Commissioner during the...

More from Regulation

More from Policy & Regulation